Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

Jung Eun Park; Hiu Fung Yuen; Jian Biao Zhou; Abdul Qader O. Al-aidaroos; Ke Guo; Peter J. Valk; Shu-Dong Zhang; Wee Joo Chng; Cheng William Hong; Ken Mills; Qi Zeng

doi:10.1002/emmm.201202183

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

Jung Eun Park, Hiu Fung Yuen, Jian Biao Zhou, Abdul Qader O. Al-aidaroos, Ke Guo, Peter J. Valk, Shu-Dong Zhang, Wee Joo Chng, Cheng William Hong, Ken Mills, Qi Zeng

Faculty Of Life & Health Sciences

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

4 Downloads (Pure)

Original language	English
Pages (from-to)	1351-1366
Journal	EMBO Molecular Medicine
Volume	5
Issue number	9
DOIs	https://doi.org/10.1002/emmm.201202183
Publication status	Published - 2013

Keywords

acute myeloid leukaemia
antibody therapy
FLT3-ITD mutation
PRL-3
prognostic marker

Access to Document

10.1002/emmm.201202183

2013-0808-EMBO-AML-PRL3-1351Final published version, 1.47 MB

Cite this

@article{99a0099b1a3b4036bf12e03e2f87222c,

title = "Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia",

keywords = "acute myeloid leukaemia, antibody therapy, FLT3-ITD mutation, PRL-3, prognostic marker",

author = "Park, {Jung Eun} and Yuen, {Hiu Fung} and Zhou, {Jian Biao} and Al-aidaroos, {Abdul Qader O.} and Ke Guo and Valk, {Peter J.} and Shu-Dong Zhang and Chng, {Wee Joo} and Hong, {Cheng William} and Ken Mills and Qi Zeng",

year = "2013",

doi = "10.1002/emmm.201202183",

language = "English",

volume = "5",

pages = "1351--1366",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "John Wiley & Sons, Inc.",

number = "9",

}

TY - JOUR

T1 - Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

AU - Park, Jung Eun

AU - Yuen, Hiu Fung

AU - Zhou, Jian Biao

AU - Al-aidaroos, Abdul Qader O.

AU - Guo, Ke

AU - Valk, Peter J.

AU - Zhang, Shu-Dong

AU - Chng, Wee Joo

AU - Hong, Cheng William

AU - Mills, Ken

AU - Zeng, Qi

PY - 2013

Y1 - 2013

KW - acute myeloid leukaemia

KW - antibody therapy

KW - FLT3-ITD mutation

KW - PRL-3

KW - prognostic marker

U2 - 10.1002/emmm.201202183

DO - 10.1002/emmm.201202183

M3 - Article

VL - 5

SP - 1351

EP - 1366

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 9

ER -